Envista Holdings Corporation

DB:0HV Stock Report

Market Cap: €3.1b

Envista Holdings Past Earnings Performance

Past criteria checks 0/6

Envista Holdings's earnings have been declining at an average annual rate of -54.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 2.4% per year.

Key information

-54.5%

Earnings growth rate

-54.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate2.4%
Return on equity-43.5%
Net Margin-53.4%
Last Earnings Update27 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Envista Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0HV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
27 Sep 242,503-1,3371,09993
28 Jun 242,534-1,3241,08289
29 Mar 242,563-1201,04693
31 Dec 232,567-1001,02994
29 Sep 232,5821911,00998
30 Jun 232,5822191,016102
31 Mar 232,5652111,023100
31 Dec 222,5692381,014100
30 Sep 222,5602071,044100
01 Jul 222,5362381,02898
01 Apr 222,5282721,01199
31 Dec 212,509264990101
01 Oct 212,47331292499
02 Jul 212,41325689495
02 Apr 211,99512280578
31 Dec 201,9294385987
02 Oct 202,033891099
03 Jul 202,14546948115
03 Apr 202,6391631,055146
31 Dec 192,285184970133
27 Sep 192,7902131,055163
28 Jun 192,8102151,061169
29 Mar 192,8322321,066174
31 Dec 182,8452311,113172
31 Dec 172,8113011,033172
31 Dec 162,7852721,034143

Quality Earnings: 0HV is currently unprofitable.

Growing Profit Margin: 0HV is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0HV is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.

Accelerating Growth: Unable to compare 0HV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0HV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 0HV has a negative Return on Equity (-43.52%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:15
End of Day Share Price 2024/12/13 00:00
Earnings2024/09/27
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Envista Holdings Corporation is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBaird
Jeffrey JohnsonBaird
Michael ChernyBofA Global Research